Rothschild Investment LLC Mirum Pharmaceuticals, Inc. Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q3 2024
A detailed history of Rothschild Investment LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 45 shares of MIRM stock, worth $1,872. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45
Previous 15
200.0%
Holding current value
$1,872
Previous $513,000
242.11%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MIRM
# of Institutions
173Shares Held
53.5MCall Options Held
96.1KPut Options Held
54.8K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$270 Million13.09% of portfolio
-
Janus Henderson Group PLC London, X04.99MShares$208 Million0.09% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$182 Million4.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.61MShares$150 Million2.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$135 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.53B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...